Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis

This study has been completed.
Sponsor:
Collaborator:
AVVAA World Healthcare Products, Inc.
Information provided by (Responsible Party):
Clinical Pharmacology, University of Medicine and Dentistry New Jersey
ClinicalTrials.gov Identifier:
NCT00143819
First received: August 31, 2005
Last updated: June 28, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)